NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its third quarter revenues were up 23 percent year over year on an adjusted basis.

The company's total revenues for the three months ended Sept. 30 were $101.3 million, compared with Q3 2017 revenues of $82.2 million adjusted for the change to ASC 606 accounting standards that the company adopted this January, and reported revenues of $83.8 million. Wall Street analysts had expected revenues of $94.4 million for the third quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.